Consultant Chemical Pathologist

Job summary

This is a full-time replacement post for a Consultant Chemical Pathologist based at Wrexham Maelor Hospital. The Clinical Biochemistry department has strong links with all clinical specialties throughout the hospital and GPs within its catchment area.

We wish to identify someone with broad experience in Clinical Biochemistry, who has a strong clinical background to provide direct clinical care in the specialist Lipid Clinic, Metabolic Stone service and involved with the multidisciplinary Parenteral Nutrition Service, which provides parenteral nutrition to inpatients and a small number of patients on long-term home parenteral nutrition. The department has close links with all clinical services, so there is scope for development of relevant collaborative clinical service or research interests.

As part of the recruitment process, candidates shortlisted for the role will be invited to attend both a Stakeholder Interview and an Advisory Appointments Committee (AAC) Interview. AAC is scheduled for 29 January 2027. The Stakeholder Interview date will be confirmed once shortlisting is complete. This is expected to be held week commencing 25 January 2027.

Main duties of the job

Clinical Workload

Clinical duties will be based at Wrexham Maelor Hospital, where the consultant will be expected to cover the weekly Lipid and Metabolic Stone Clinics on-site.

The Lipid Clinic service operates in conjunction with the Familial Hypercholesterolaemia (FH) Genetic Screening Programme for patients across Wrexham and Flintshire. The appointee will work closely with the North Wales FH Nurse Specialist to actively identify candidates for FH genotyping and manage complex, difficult-to-treat FH cases throughout the region. The clinic also oversees the review and management of patients requiring injectable therapies. Additionally, a significant volume of primary care lipid referrals are managed via clinical advice and office-based decision letters, bypassing the need for in-person clinic visits. Direct electronic access across primary and secondary care systems streamlines this process, handling a steady influx of weekly advisory requests.

The Metabolic Stone Clinic receives referrals from across all three BCUHB hospitals, managing a broad case mix of cystinuria, calcium phosphate, calcium oxalate, and uric acid stone formers. Clear referral guidelines has been established with the urological team to maintain an efficient caseload across the region.

About us

Betsi Cadwaladr University Health Board (BCUHB) is Wales's largest health organisation, with a budget of over £2.4 billion and a workforce of over 20,000 staff.

BCUHB provides a full range of primary, community, mental health, acute and specialist hospital services for the population of North Wales, across 3 acute hospitals and a network of community hospitals, health centres, clinics, and mental health units. It also co-ordinates or provides the work of GP practices and NHS services provided by dentists, opticians, and pharmacists across the region.

The Health Board is an integrated health system that strives for excellent, compassionate care delivered in partnership with the public sector and other statutory and third sector organisations.